当前位置:首页 - 行情中心 - 睿智医药(300149) - 财务分析 - 现金流量表

睿智医药

(300149)

  

流通市值:55.57亿  总市值:58.31亿
流通股本:4.75亿   总股本:4.98亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金533,876,099.3239,553,771.911,004,001,952.96747,520,793.71
  收到的税费返还19,989,504.512,613,698.7837,662,12627,758,795.05
  收到其他与经营活动有关的现金29,151,254.935,777,305.1731,965,640.5512,918,226.43
  经营活动现金流入小计583,016,858.73257,944,775.861,073,629,719.51788,197,815.19
  购买商品、接受劳务支付的现金215,206,485.71101,349,015.83288,669,738.97226,264,403.55
  客户贷款及垫款净增加额--0-
  存放中央银行和同业款项净增加额--0-
  支付原保险合同赔付款项的现金--0-
  支付利息、手续费及佣金的现金--0-
  支付保单红利的现金--0-
  支付给职工以及为职工支付的现金273,972,450.02138,759,519.4539,393,030.71413,145,517.31
  支付的各项税费10,911,502.021,330,160.3812,247,988.7712,231,689.55
  支付其他与经营活动有关的现金17,591,336.596,447,333.4965,111,669.9824,011,085.93
  经营活动现金流出的其他项目--0-
  经营活动现金流出小计517,681,774.34247,886,029.1905,422,428.43675,652,696.34
  经营活动产生的现金流量净额65,335,084.3910,058,746.76168,207,291.08112,545,118.85
二、投资活动产生的现金流量:
  收回投资收到的现金30,00030,000-0
  取得投资收益收到的现金23,695.95230.14228,438.57192,763.74
  处置固定资产、无形资产和其他长期资产收回的现金净额30,003,3502,210160,754.255,220
  处置子公司及其他营业单位收到的现金净额---0
  收到的其他与投资活动有关的现金31,555,864.86600,090.186,832,022.295,608,022.29
  投资活动现金流入小计61,612,910.81632,530.327,221,215.115,806,006.03
  购建固定资产、无形资产和其他长期资产支付的现金30,068,772.958,182,154.4269,245,662.0758,513,346.97
  投资支付的现金10,050,000--1,000,000
  支付其他与投资活动有关的现金49,700,0003,800,0005,644,0004,720,000
  投资活动现金流出小计89,818,772.9511,982,154.4274,889,662.0764,233,346.97
  投资活动产生的现金流量净额-28,205,862.14-11,349,624.1-67,668,446.96-58,427,340.94
三、筹资活动产生的现金流量:
  取得借款收到的现金1,000,000-21,000,00028,450,000
  收到其他与筹资活动有关的现金35,300,000-37,450,000-
  筹资活动现金流入平衡项目0-00
  筹资活动现金流入小计36,300,000-58,450,00028,450,000
  偿还债务支付的现金4,260,000-54,280,00062,130,000
  分配股利、利润或偿付利息支付的现金1,178,828.85-149,780.992,876,300.42,354,400.22
  支付其他与筹资活动有关的现金80,670,392.4919,579,961.2887,730,047.9445,179,855.76
  筹资活动现金流出小计86,109,221.3419,430,180.29144,886,348.34109,664,255.98
  筹资活动产生的现金流量净额-49,809,221.34-19,430,180.29-86,436,348.34-81,214,255.98
四、汇率变动对现金及现金等价物的影响633,349.4314,695.077,117,000.81-1,598,568.52
五、现金及现金等价物净增加额-12,046,649.69-20,406,362.5621,219,496.59-28,695,046.59
  加:期初现金及现金等价物余额363,448,871.8363,406,399.37342,229,375.21342,229,375.21
  期末现金及现金等价物余额351,402,222.11343,000,036.81363,448,871.8313,534,328.62
补充资料:
  净利润25,345,366.23--226,512,315.17-
  资产减值准备14,443,974.16-186,446,098.54-
  固定资产和投资性房地产折旧28,185,850.01-57,171,171.27-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧28,185,850.01-57,171,171.27-
  无形资产摊销1,457,197.75-2,392,617.35-
  长期待摊费用摊销22,678,784.45-47,750,799.44-
  处置固定资产、无形资产和其他长期资产的损失-6,261,722.68--8,433,398.14-
  固定资产报废损失368,870.39-14,689,405.13-
  公允价值变动损失15,167.73-2,296,500-
  财务费用6,333,606.42-14,414,314.05-
  投资损失-12,893,493.74--10,091,924.67-
  递延所得税-1,642,109.91--8,716,557.55-
  其中:递延所得税资产减少-2,345,794.3-987,549.95-
    递延所得税负债增加703,684.39--9,704,107.5-
  存货的减少-1,976,714.9-7,011,672.96-
  经营性应收项目的减少-44,063,422.47-58,805,332.1-
  经营性应付项目的增加-355,188.92--41,244,096.99-
  其他1,892,070.64---
  现金的期末余额351,402,222.11-363,448,871.8-
  减:现金的期初余额363,448,871.8-342,229,375.21-
  现金及现金等价物的净增加额-12,046,649.69-21,219,496.59-
公告日期2025-08-292025-04-292025-04-292024-10-30
审计意见(境内)标准无保留意见
TOP↑